EUCTR2016-001503-23-CZ进行中（未招募）1 期
Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Long-term Safety and Efficacy of Caplacizumab (Post-HERCULES)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Ablynx NV
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Each potential subject must satisfy all of the following criteria to be enrolled in the study:
- •1.Completed the Final (28 day) FU visit in Study ALX0681-C301.
- •2.Is =18 years of age at the time of signing the informed consent form (ICF).
- •3.Provided informed consent prior to initiation of any study specific activity/procedure.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 95
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 9
排除标准
- •The criteria for exclusion are the following:
- •1.Not being able/willing to comply with the study protocol procedures.
- •2.Currently enrolled in a clinical study with another investigational drug or device.
研究者
相似试验
进行中（未招募）
1 期
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)Acquired thrombotic thrombocytopenic purpura (TTP)MedDRA version: 20.0Level: PTClassification code 10043648Term: Thrombotic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2016-001503-23-ATAblynx NV104
尚未招募
3 期
Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Long-term Safety and Efficacy of Caplacizumab (Post-HERCULES)Thrombotic Thrombocytopenic Purpura10038158NL-OMON43030Ablynx NV8
进行中（未招募）
1 期
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)EUCTR2016-001503-23-GBAblynx NV104
进行中（未招募）
1 期
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)Acquired thrombotic thrombocytopenic purpura (TTP)MedDRA version: 20.0Level: PTClassification code 10043648Term: Thrombotic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2016-001503-23-NLAblynx NV92
进行中（未招募）
1 期
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)EUCTR2016-001503-23-FRAblynx NV92